William Blair Has Positive Forecast for PBH FY2025 Earnings

Prestige Consumer Healthcare Inc. (NYSE:PBH) – Equities research analysts at William Blair increased their FY2025 earnings per share estimates for Prestige Consumer Healthcare in a research note issued to investors on Thursday, February 6th. William Blair analyst J. Andersen now forecasts that the company will earn $4.50 per share for the year, up from their prior estimate of $4.42. The consensus estimate for Prestige Consumer Healthcare’s current full-year earnings is $4.50 per share. William Blair also issued estimates for Prestige Consumer Healthcare’s Q4 2025 earnings at $1.30 EPS and FY2026 earnings at $4.75 EPS.

Other research analysts also recently issued reports about the stock. Raymond James upgraded shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday, December 19th. StockNews.com upgraded Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Friday, January 24th. Sidoti lowered Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 target price on the stock. in a report on Monday, December 9th. Canaccord Genuity Group boosted their price target on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a report on Friday. Finally, DA Davidson raised their price objective on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a research note on Friday. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Prestige Consumer Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $92.50.

Prestige Consumer Healthcare Stock Up 0.3 %

PBH stock opened at $87.29 on Monday. The company has a market capitalization of $4.31 billion, a P/E ratio of 20.44, a price-to-earnings-growth ratio of 2.43 and a beta of 0.50. Prestige Consumer Healthcare has a 12 month low of $62.35 and a 12 month high of $88.36. The firm’s fifty day simple moving average is $79.23 and its 200-day simple moving average is $75.51. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.10.

Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Thursday, February 6th. The company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%.

Insider Transactions at Prestige Consumer Healthcare

In related news, CEO Ronald M. Lombardi sold 10,875 shares of the company’s stock in a transaction dated Tuesday, November 19th. The shares were sold at an average price of $82.60, for a total value of $898,275.00. Following the completion of the sale, the chief executive officer now owns 320,952 shares of the company’s stock, valued at approximately $26,510,635.20. This represents a 3.28 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 1.60% of the company’s stock.

Hedge Funds Weigh In On Prestige Consumer Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of PBH. Northwestern Mutual Wealth Management Co. raised its position in shares of Prestige Consumer Healthcare by 562.3% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company’s stock valued at $35,000 after buying an additional 433 shares during the period. SG Americas Securities LLC acquired a new stake in Prestige Consumer Healthcare during the third quarter worth $364,000. GAMMA Investing LLC raised its position in Prestige Consumer Healthcare by 49.9% in the third quarter. GAMMA Investing LLC now owns 1,163 shares of the company’s stock valued at $84,000 after purchasing an additional 387 shares during the period. Inspire Investing LLC lifted its stake in shares of Prestige Consumer Healthcare by 11.7% in the 3rd quarter. Inspire Investing LLC now owns 5,702 shares of the company’s stock valued at $411,000 after purchasing an additional 599 shares during the last quarter. Finally, Exchange Traded Concepts LLC grew its holdings in shares of Prestige Consumer Healthcare by 6.3% during the 3rd quarter. Exchange Traded Concepts LLC now owns 22,801 shares of the company’s stock worth $1,644,000 after purchasing an additional 1,343 shares during the period. 99.95% of the stock is currently owned by institutional investors and hedge funds.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.